Patricia F. Kao, Ph.D. - Publications

Affiliations: 
Boston University, Boston, MA, United States 
Area:
Cytoskeleton and neurodegeneration

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Choi JL, Kao PF, Itriago E, Zhan Y, Kozubek JA, Hoss AG, Banigan MG, Vanderburg CR, Rezvani AH, Latourelle JC, Cabral H, Delalle I. miR-149 and miR-29c as candidates for bipolar disorder biomarkers. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. PMID 28190298 DOI: 10.1002/Ajmg.B.32518  0.618
2015 Zhan X, Jickling GC, Ander BP, Stamova B, Liu D, Kao PF, Zelin MA, Jin LW, DeCarli C, Sharp FR. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain. Journal of Alzheimer's Disease : Jad. 44: 1213-29. PMID 25697841 DOI: 10.3233/Jad-142013  0.386
2014 Fang YS, Tsai KJ, Chang YJ, Kao P, Woods R, Kuo PH, Wu CC, Liao JY, Chou SC, Lin V, Jin LW, Yuan HS, Cheng IH, Tu PH, Chen YR. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients. Nature Communications. 5: 4824. PMID 25215604 DOI: 10.1038/Ncomms5824  0.363
2014 Delalle I, Kao PF, Choi J. Deregulated microRNA expression in biospecimens from patients diagnosed with schizophrenia and bipolar disorder as a disease biomarker Translational Neuroscience. 5: 173-178. DOI: 10.2478/S13380-014-0224-8  0.652
2013 Banigan MG, Kao PF, Kozubek JA, Winslow AR, Medina J, Costa J, Schmitt A, Schneider A, Cabral H, Cagsal-Getkin O, Vanderburg CR, Delalle I. Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients. Plos One. 8: e48814. PMID 23382797 DOI: 10.1371/Journal.Pone.0048814  0.629
2012 Kao PF, Banigan MG, Vanderburg CR, McKee AC, Polgar PR, Seshadri S, Delalle I. Increased expression of TrkB and Capzb2 accompanies preserved cognitive status in early Alzheimer disease pathology. Journal of Neuropathology and Experimental Neurology. 71: 654-64. PMID 22710966 DOI: 10.1097/Nen.0B013E31825D06B7  0.66
2012 Gräff J, Rei D, Guan JS, Wang WY, Seo J, Hennig KM, Nieland TJ, Fass DM, Kao PF, Kahn M, Su SC, Samiei A, Joseph N, Haggarty SJ, Delalle I, et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature. 483: 222-6. PMID 22388814 DOI: 10.1038/Nature10849  0.625
2010 Vanderburg CR, Davis DA, Diamond RE, Kao PF, Delalle I. Capzb2 PROTEIN EXPRESSION IN THE BRAINS OF PATIENTS DIAGNOSED WITH ALZHEIMER'S DISEASE AND HUNTINGTON'S DISEASE. Translational Neuroscience. 1: 55-58. PMID 29662700 DOI: 10.2478/V10134-010-0008-9  0.672
2010 Kao PF, Davis DA, Banigan MG, Vanderburg CR, Seshadri S, Delalle I. Modulators of cytoskeletal reorganization in CA1 hippocampal neurons show increased expression in patients at mid-stage Alzheimer's disease. Plos One. 5: e13337. PMID 20967212 DOI: 10.1371/Journal.Pone.0013337  0.654
2010 Vanderburg CR, Davis DA, Diamond RE, Kao PF, Delalle I. Capzb2 protein expression in the brains of patients diagnosed with alzheimer's disease and huntington's disease Translational Neuroscience. 1: 55-58. DOI: 10.2478/v10134-010-0008-9  0.643
Show low-probability matches.